The relevance of D2-AKT1 signalling for the pathophysiology of cannabis-induced psychosis.
|
|
- Walter Booth
- 5 years ago
- Views:
Transcription
1 The relevance of D2-AKT1 signalling for the pathophysiology of cannabis-induced psychosis Edinburgh, 14 April 2016 Dr Marco Colizzi
2 Developmental cascade towards psychosis Family history of mental illness disorders Birth events -Prenatal and perinatal events -Genes:** NRG1, DTNBP1, COMT, DISC1, DRD2, RM3, ZNF, CNVs Chronic social adversity in childhood Subtle motor, cognitive and social deficits HPA-axis dysfunction Adulthood adversity Migration Urbanicity Social anxiety, Quasi-psychotic ideas, depression -Drug abuse e.g. cannabis, stimulants Dopamine dysregulation Neurotransmiters genes: e.g. **COMT; AKT1 P S Y C H O S I S
3 An integrated model of schizophrenia Howes & Murray, Lancet 2014
4 Cannabis and psychosis Questions Does cannabis trigger an earlier onset of psychosis in predisposed people? Does cannabis use worsen the psychotic symptoms generally? Does the cannabis use worsen the outcome and progress of the illness? Is there a causal link?
5 Cannabis plant A complex plant with over 60 compounds and 400 chemicals. There are 4 major compounds: THC (Gul et al., 2008) Delta-9-tetrahydrocannabinol (THC) * Cannabidiol (CBD) Delta-8-tetrahydrocannabinol * Cannabinol * CBD (Gul et al., 2008) *= has psychotogenic effect
6 Cannabis and endocannabinoid system Tetrahydrocannabinol (THC) Name Part of plant THC % Marijuana Leaves, small stems Sinsemilla Sterile female flowers Ganja Compressed sterile f.f Hashish Cannabis resin Skunk Flowers (grown) Cannabis oil Alcoholic extract of resin Cannabidiol (CBD) No psychotomimetic effects in man Anti-epileptic, anti-anxiety and anti-psychotic effects in men and animals No significant side-effects. Even large doses have been tolerated Hollister, 1975; Zuardi et al., 1982; Pellow et al., 1985; Agurell et al, 1986; Zuardi & Guimaraes, 1997; Crippa et al., 2004 Sinsemilla potency comparison 1996/8 v 2005 UK (Potter et al., 2008) Potency levels signifantly higher in 2005 (p<0.001) Endocannabinoid system 1988: A specific cannabinoid receptor was found in the rat brain (Devane-Howlett, 1988) 1990: The discovery of a complementary DNA encoding for the first G protein-coupled cannabinoid receptor, now known as CB1 (Matsuda et al., 1990) 1992: The discovery of the neurotransmitter, a brain molecule called anandamide was identified (Devane-Mechoulam, 1992) 1993: The discovery of the second neurotransmitter, arachidonoyglycerol (2-AG, Munro et al., 1993)
7 Existing evidence Studies Epidemiological studies Clinical studies Biochemical studies Genetic studies Imaging studies
8 Epidemiological studies - A causal link: Swedish study (1969) of 50,000 Swedish conscripts followed up for 15 years showed an increased risk amongst those who smoked cannabis; 1. those who were heavy users at age 18 were 6 times more likely to develop schizophrenia over the next 15 years; 2. increased risk in those who have genetic vulnerability (i.e.; someone else in family suffers from severe mental illness (Andreasson et al., 1987). - The reanalysis of the Swedish study showed that there is an associated risk of developing schizophrenia consistent with a causal relation. This association is not explained by use of other drugs or personality traits (Zammit et al., 2002). - A Dutch study: 7500 people followed for 3 years. Regular consumers were more likely to develop schizophrenia (Van Os et al., 2002). - The Prospective Dunedin (New Zealand) Multidisciplinary Health and Development Study: 1037 individuals followed up from birth in New Zealand (Arseneault et al., 2002) 1. At age 11: information on psychotic symptoms 2. At ages 15, 18: their drug use assessed 3. At age 26: their psychotic symptoms assessed The study found that people who used cannabis by the age of 15 were four times as likely to show an increase in SCZ symptoms at the age of 26.
9 Epidemiological studies Systematic review of studies, cannabis use and psychosis risk (Moore et al., 2007) Systematic review of evidence related to cannabis use and occurrence of mental health outcomes Longitudinal and population based studies Cannabis use increases the risk of development of a psychotic illness in a dose dependent manner No strong evidence as yet that earlier cannabis use is particularly harmful Systematic meta-analysis, cannabis use and earlier onset of psychosis (Large et al., 2011) 443 articles: 83 studies met the inclusion criteria, involving: substance-using patients non-substance-using patients Meta-analysis of age at onset of psychosis revealed that the age at onset was 2.70 years earlier among samples of cannabis users (p<.001) A further meta-analysis of other confounding factors (Large et al., 2012) Possible confounding factors including: - Tobacco use - Diagnosis - Male gender - Study quality The association between cannabis use and earlier onset of psychosis is robust It is not the result of tobacco smoking by cannabis using patients or the other potentially confounding factors
10 Clinical studies Review of clinical studies (Atakan et al., 2008) Cannabis use in those with serious mental illness has been associated with: Poor social functioning Increased rates of violence Increased rates of suicide Increased rates of victimization Homelessness Criminal behaviour Poorer physical health Heavy burden on health services Early psychotic breakdown Exacerbation or precipitation of symptoms Poor adherence to treatment Increased rates of hospitalization Increased duration of hospitalization Increased duration of psychotic episode
11 The adverse effect of cannabis use on outcome of First Episode Psychosis is mediated by poor medication adherence Colizzi et al., 2015 Schizophrenia Research
12 Biochemical studies - The main psychotomimetic compound of the cannabis plant, delta-9-thc has an agonist/partial agonist effect on CB1 receptors (Pertwee, 2008) - Endocannabinoid and dopaminergic systems are co-localized in the CNS - Dopamine alterations have been reported in patients with schizophrenia (Laurelle, 1998) - Delta-9-THC increases dopamine release in the human striatum (Murray et al., 2014) - CBD reduces anxiety and has a profile similar to atypical antipsychotics (Atakan, 2008) Genetic studies Gene environment interaction studies have mainly focussed on genetic variants involved in the regulation of the dopaminergic system: - COMT (Caspi et al., 2005) - AKT1 (van Winkel et al., 2011; Di Forti et al., 2012) - DAT1 (Bhattacharyya et al., 2012) - BDNF Val66Met (Decoster et al., 2011) - CNR1 and NRG1 (Pelayo-Teran et al., 2012) Some genes seem to explain susceptibility to cannabis related psychosis Imaging studies - Long-term heavy cannabis users: reduction in bilateral hippocampal and amygdala volumes (Yucel et al., 2008) - First Episode Psychosis (FEP) cannabis users: decrease in GM density in the right posterior cingulate cortex, when compared with FEP with no cannabis use (Bangalore et al., 2008) - CNR1 rs by cannabis use interaction on bilateral hippocampus volumes (Schacht et al., 2012) Cannabis use alters the brain structure
13 Not every cannabis user develops psychosis.. Atakan et al., 2012
14 Cannabis and psychosis: the role of DRD2 gene DRD2 gene (11q22-q23 ) D2L D2S
15 Interaction between functional genetic variation of DRD2 and cannabis use on risk of psychosis and on schizotypy and working memory Interaction between DRD2 rs and cannabis use on healthy subjects Working Memory Test (2-back) accuracy Interaction between DRD2 rs and cannabis use on healthy subjects Schizotypy (SPQ questionnaire) N = 252 N = 252 Interaction between DRD2 rs and cannabis use (lifetime and frequency of use) on psychosis risk N = 506 N = 439 *Adjusted for gender, age, ethnicity, alcohol, stimulants and tobacco use Colizzi et al., 2015 Schizophrenia Bulletin
16 Dopamine-related behaviors Beyond camp: the regulation of AKT and GSK3 by dopamine receptors The effect of given genotype(s) on the risk of a disease can change in magnitude and direction (qualitative interaction) depending on the degree of environmental exposure
17 Interaction between DRD2 and AKT1 genetic variation on risk of psychosis in cannabis users Interaction between DRD2 rs /akt1 rs and cannabis use (lifetime and frequency of use) on psychosis risk N = 450 N = 402 Colizzi et al., 2015 Nature Schizophrenia
18 Questions What do we know now? Does cannabis trigger an earlier onset of psychosis in predisposed people? Yes Does cannabis exacerbate the psychotic symptoms generally? Yes Does the cannabis use worsen the outcome and progress of the illness? Yes Is there a causal link? Yes, but only in those with a predisposition to psychosis
19 Cannabis and psychosis: is it just dopamine? To summarize.. Involvement of presynaptic dopamine dysfunction in psychosis is compelling (Howes & Murray, Lancet 2014) Vulnerability to the psychotogenic effects of cannabis use involves genes that control dopamine signalling postsynaptically (Colizzi et al., 2015) What about direct effect of THC on dopamine? Little evidence to suggest that cannabis use affected acute striatal dopamine release or chronic dopamine receptor status in humans (Sami et al., 2015)
20 Cannabis and psychosis: the role of CNR1 gene CNR1 gene (6q14-q15 ) Endogenous ligands Cannabis
21 Functional genetic variation of the CNR1 and cannabis use interact on prefrontal connectivity and related working memory behavior Association between CNR1 rs and postmortem CNR1 prefrontal mrna expression Interaction between CNR1 rs and cannabis use on healthy subjects Working Memory Test (2-back) accuracy N = 208 Interaction between CNR1 rs and cannabis use on Left VLPFC during Working Memory Test (2-back) N = 208 Colizzi et al., 2014 Neuropsychopharmacology
22 Cannabis and glutamate -> it is thought that cannabis or Δ9-THC may not act on dopamine firing directly but indirectly by altering glutamate neurotransmission. Limited research carried out in humans tends to support the evidence that chronic cannabis use reduces levels of glutamate-derived metabolites in both cortical and subcortical brain areas. Research in animals tends to consistently suggest that 1. Δ9-THC depresses glutamate synaptic transmission via CB1 receptor activation, 2. disrupting glutamate synaptic plasticity after prolonged exposure, affecting glutamate release, inhibiting 3. receptors and 4. transporters function, 5. reducing enzyme activity
23 Hypotheses under investigation 1. is to employ a placebocontrolled acute pharmacological challenge design to test the hypothesis that relative to placebo acute 9 -THC administration will be associated with a reduction in glutamate levels as indexed by proton magnetic resonance spectroscopy (1H-MRS) in the hippocampus and striatum Hypofunction in glutamate neurotransmission: primary deficit determining the dopamine abnormalities consistently reported in schizophrenia (Howes et al., 2015)
24 Hypotheses under investigation 2. acute administration of 9 -THC will be associated with the induction of transient psychotic symptoms in these healthy volunteers and that these effects on symptoms will be directly related to the changes in glutamate in the proposed brain areas induced by it
25 Hypotheses under investigation 3. effect of acute 9 -THC on hippocampal activity while performing a verbal paired associate learning task, and test for a mediating effect of altered glutamate neurotransmission in the association between acute cannabis exposure and hippocampal dysfunction during verbal memory processing 9 -THC and memory 9 -THC reduces hippocampal neuron activation, relevant to memory formation Brain imaging studies show regular 9 -THC users have a smaller hippocampus 9 -THC affects memory in healthy subjects
26 Conclusions The present results support the theory that some individuals carry genetic vulnerability to the psychotogenic effect of cannabis. The character of this vulnerability is likely to be a polygenic gene-environment interaction. Identifying those genes and organizing them into genetic pathways will facilitate understanding the mechanisms that modulate the relationship between cannabis exposure and psychosis.
27 Acknowledgments Prof. Alessandro Bertolino Group of Neuroscience, Bari Prof. Sir Robin M Murray Dr. Marta Di Forti GAP study, London Dr Sagnik Bhattacharyya Prof. Philip McGuire
Cannabinoids in Medicine An Option? Psychiatric Diseases
Swiss Task Force for Cannabinoids in Medicine, STCM Bern, January 22 nd, 2013 Cannabinoids in Medicine An Option? Psychiatric Diseases S S A M Dr. med. Robert Hämmig Psychiatrie & Psychotherapie FMH Präsident
More informationThe Link between Marijuana &
The Link between Marijuana & mental illness A Survey of Recent Research OFFICE OF NATIONAL DRUG CONTROL POLICY EXECUTIVE OFFICE OF THE PRESIDENT July 2007 TABLE OF CONTENTS Overview of Marijuana and Mental
More information2018/05/01 DISCLOSURE EFFECTS OF CANNABIS USE IN ADOLESCENTS
DISCLOSURE EFFECTS OF CANNABIS USE IN ADOLESCENTS No conflict of interest to declare No pharmaceutical industry support No support from cannabis producers Selene Etches MD, FRCPC Cannabis is the most widely
More informationTHE HEALTH EFFECTS OF NONMEDICAL CANNABIS USE. Dr Nirvana Morgan Specialist Psychiatrist PhD Fellow
THE HEALTH EFFECTS OF NONMEDICAL CANNABIS USE Dr Nirvana Morgan Specialist Psychiatrist PhD Fellow nirvana.morgan@wits.ac.za ACKNOWLEDGEMENTS AND DISCLOSURE Recipient of a Cassandra Miller-Butterworth
More informationEffects of Marijuana On Brain, Body & Behavior. Nora D. Volkow, MD Director
Effects of Marijuana On Brain, Body & Behavior Nora D. Volkow, MD Director Marijuana is the Most Commonly Used Illicit Drug In the U.S. Over 111 million Americans have tried it at least once An estimated
More informationEffects of Marijuana On Brain, Body & Behavior. Nora D. Volkow, MD Director
Effects of Marijuana On Brain, Body & Behavior Nora D. Volkow, MD Director Marijuana is the Most Commonly Used Illicit Drug In the U.S. Over 111 million Americans have tried it at least once An estimated
More informationCannabis. Member of the Cannabaceae family of flowering plants (along with hops) Cannabis sativa (v. sativa, indica, afghanica, ruderalis)
Member of the Cannabaceae family of flowering plants (along with hops) sativa (v. sativa, indica, afghanica, ruderalis) Only females flowers contain high concentrations of psychoactive oils (cannabinoids)
More informationUNDERSTANDING TEENAGE DRUG USE. Dr DES CORRIGAN Sligo Oct 13 th 2012
UNDERSTANDING TEENAGE DRUG USE Dr DES CORRIGAN Sligo Oct 13 th 2012 LAST MONTH USE (CURRENT USE) Drug Left School Early Still in School National Survey (18-64) Cigarettes 70% 27% 28% Alcohol 66% 56% 71%
More informationResearch on Cannabis and PD: Is there any evidence?
Research on Cannabis and PD: Is there any evidence? Benzi M. Kluger, MD, MS Associate Professor of Neurology and Psychiatry Director Movement Disorders Center University of Colorado Denver DISCLOSURES
More informationMarijuana is the Most Commonly Used Illicit Drug In the U.S.
Effects of Marijuana On Brain, Body & Behavior Marijuana is the Most Commonly Used Illicit Drug In the US Nora D Volkow, MD Director Over million Americans have tried it at least once An estimated million
More informationCannabidiol as a potential treatment for anxiety disorders. Esther Blessing, MD PhD
Cannabidiol as a potential treatment for anxiety disorders Esther Blessing, MD PhD Overview History and of cannabidiol (CBD) and cannabis Safety and tolerability of CBD CBD pharmacology Clinical need for
More informationMarijuana Science Update
Marijuana Science Update Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse ADVANCING ADDICTION SCIENCE NIDA CANNABIS SCIENCE RESEARCH AREAS EPIDEMIOLOGY: National and Local
More informationNeuroscience and Biobehavioral Reviews
Neuroscience and Biobehavioral Reviews 35 (2011) 1779 1787 Contents lists available at ScienceDirect Neuroscience and Biobehavioral Reviews jou rnal h omepa ge: www.elsevier.com/locate/neubiorev Review
More informationMedical Marijuana. 1. is a plant species, variety known as hemp. 3. Tetrahydrocannabinol is an aromatic with low water solubility.
Medical Marijuana Questions from Part 1: 1. is a plant species, variety known as hemp. a. Cannabis sativa Linnaeus b. Cannabis sativa c. Cannabis indica d. Cannabis Lemark 2. The major psychoactive compound
More informationmarijuana and the teen brain MARY ET BOYLE, PH. D. DEPARTMENT OF COGNITIVE SCIENCE UCSD
marijuana and the teen brain MARY ET BOYLE, PH. D. DEPARTMENT OF COGNITIVE SCIENCE UCSD in this talk what is marijuana? the brain on marijuana is the teen brain special? current research what is marijuana?
More informationmarijuana and the teen brain MARY ET BOYLE, PH. D. DEPARTMENT OF COGNITIVE SCIENCE UCSD
marijuana and the teen brain MARY ET BOYLE, PH. D. DEPARTMENT OF COGNITIVE SCIENCE UCSD in this talk what is marijuana? the brain on marijuana is the teen brain special? current research what is marijuana?
More informationMarijuana and Adolescents: Truth and Consequences. Disclosure Statement OBJECTIVES. Secondary Objectives. State of Marijuana in US
Marijuana and Adolescents: Truth and Consequences Clinical Advances in Pediatrics Symposium Children s Mercy Park September 28, 2017 Disclosure Statement I have no actual or potential conflict of interest
More informationCannabinoids and Mental Health
Cannabinoids and Mental Health https://upload.wikimedia.org/wikipedia/commons Karen M. Lounsbury, PhD Professor of Pharmacology 802-656-3231, Karen.lounsbury@uvm.edu Objectives Describe the underlying
More informationCannabis consumption and the risk of psychosis
original article Cannabis consumption and the risk of psychosis Summary Objectives: Cannabis is the most widely used illicit drug globally and its use has been linked to an increased risk for psychotic
More informationFinal parade Handover
2019 Leaders Final parade Handover Our final parade for the year saw the 2018 student executive hand over to the 2019 student leaders. It was also an opportunity for our Year 12 students to say farewell
More informationESSENTIAL PSYCHOPHARMACOLOGY, Neurobiology of Schizophrenia Carl Salzman MD Montreal
ESSENTIAL PSYCHOPHARMACOLOGY, 2011 Neurobiology of Schizophrenia Carl Salzman MD Montreal EVOLVING CONCEPTS OF SCHIZOPHRENIA Psychotic illness with delusions, hallucinations, thought disorder and deterioration;
More informationCANNABIS LEGALIZATION: SUPPORT MATERIAL FOR MANITOBA PHYSICIANS
CANNABIS LEGALIZATION: SUPPORT MATERIAL FOR MANITOBA PHYSICIANS 1. GENERAL INFORMATION Cannabis 101 What is cannabis? Cannabis is a product derived from the Cannabis sativa plant. Cannabis contains hundreds
More informationThe Neurobiology of Mood and Psychotic Disorders
The Neurobiology of Mood and Psychotic Disorders Daphne J. Holt, MD, PhD Co-Director, Schizophrenia Clinical and Research Program Department of Psychiatry, Massachusetts General Hospital Associate Professor,
More informationOutline. Outline. Background Literature and Slides 10/23/2013. The Schizophrenia Research Forum online: Molecules, Neural Networks and Behavior
Background Literature and Slides Molecules, Neural Networks and Behavior Roberto Fernández Galán, PhD Assistant Professor of Neurosciences Mt. Sinai Health Care Foundation Scholar Alfred P. Sloan Research
More informationUnderstanding the Effects of Marijuana in Psychosis and Schizophrenia
Understanding the Effects of Marijuana in Psychosis and Schizophrenia F ILOLI, MAY 24, 2018 Doug Noordsy, MD Clinical Professor of Psychiatry & Behavioral Sciences INSPIRE early psychosis clinic Director
More information50 Shades of Developing Gray Matter: Adolescents and Marijuana
50 Shades of Developing Gray Matter: Adolescents and Marijuana Ken Winters, Ph.D. Department of Psychiatry University of Minnesota winte001@umn.edu MNCAMH Webinar October 10, 2014 www.psychiatry.umn.edu/research/casar/home.html
More informationPOT WEED CHRONIC GREEN KUSH BUD HERB
POT WEED CHRONIC GREEN KUSH BUD HERB WHAT MOTIVATES YOU TO USE POT?* AVOID USING CANNABIS RELAXES ME HELPS ME FIT IN HELPS ME FORGET MAKES ME FEEL HAPPY HELPS ME SLEEP CHANGES MY REALITY *Though there
More informationMARIJUANA & THE EFFECTS ON THE BRAIN
MARIJUANA & THE EFFECTS ON THE BRAIN Sheryl Ryan, MD Professor of Pediatrics Chief, Division of Adolescent Medicine, Penn State Health Hershey Medical Center DISCLOSURES I have no relevant financial relationships
More informationCannabis for Medical Use: Body and Mind
Cannabis for Medical Use: Body and Mind Shaul Schreiber, MD Division of Psychiatry, Tel Aviv Sourasky Medical Center; Tel Aviv University Sackler Faculty of Medicine; Sagol School of Neuroscience, Israel
More informationmarijuana and the teen brain MARY ET BOYLE, PH. D. DEPARTMENT OF COGNITIVE SCIENCE UCSD
marijuana and the teen brain MARY ET BOYLE, PH. D. DEPARTMENT OF COGNITIVE SCIENCE UCSD in this talk what is marijuana? the brain on marijuana is the teen brain special? current research what is marijuana?
More informationCANNABIS FOR THE RHEUMATOLOGIST
CANNABIS FOR THE RHEUMATOLOGIST Dr Jagtar Singh Nijjar NIHR Clinical Lecturer in Rheumatology Disclosures None 1 Overview The history of cannabis use Anecdotal use of cannabis in chronic pain The biology
More informationMedical Marijuana Myths and Realities
Medical Marijuana Myths and Realities Herbert D. Kleber, M.D. Professor of Psychiatry Director, Division on Substance Abuse Columbia University/NYSPI October 8, 2013 THS 2013 Biarritz Introduction Marijuana
More informationThe Scientific Side of Medical Marijuana
The Scientific Side of Medical Marijuana Ken Mackie, MD Indiana University Bloomington, IN December 3, 2009 kmackie@indiana.edu Financial disclosures NIH (NIDA) - research grants Alzheimer s Association
More informationSupplementary appendix
Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Schoeler T, Petros N, Di Forti M, et al. Poor
More informationPsychology 320: Topics in Physiological Psychology Lecture Exam 2: March 19th, 2003
Psychology 320: Topics in Physiological Psychology Lecture Exam 2: March 19th, 2003 Name: Student #: BEFORE YOU BEGIN!!! 1) Count the number of pages in your exam. The exam is 8 pages long; if you do not
More informationWhy Adolescents are at Risk for Substance Abuse and Addiction
Why Adolescents are at Risk for Substance Abuse and Addiction Ken Winters, Ph.D. Addiction Researcher winte001@umn.edu AARC Community Education & Prevention September 20, 2016 1. Brain development 4. How
More informationMarijuana and cannabinoids
Psych 181: Dr. Anagnostaras Lec 10: Marijuana Marijuana and cannabinoids Cannabis sativa, hemp One of earliest non-food plants cultivated fiber for rope, seeds for oil and birdseed 1st archaeological evidence
More informationHistory Of Medical Cannabis
History Of Medical Cannabis Historical and archaeological evidence of widespread use in ancient times as medicine, food, textiles & for sacraments, rituals Possibly first domesticated crop Introduction
More informationCannabis Use: Scope of the Issue
Three Areas of Focus How Changing Cannabis Policy Will Affect Your Practice Kevin P. Hill, MD, MHS Director, McLean Hospital Division of Alcohol and Drug Abuse Belmont, MA Assistant Professor of Psychiatry,
More informationCannabinoids (CB): Outline. CB: Epidemiology. CB: Categorization. CB: Pharmacodynamics. Part #1: Cannabinoid (CB) Primer.
Cannabinoids (CB): Outline 1 2 PART #1: CB Primer Epidemiology Categorization: Endogenous vs. exogenous Natural vs. synthetic Pharmacodynamics (PD) Pharmacokinetics (PK) CB receptor system CNS regional
More informationThe Environment and Schizophrenia: The role of Cannabis Use
The Environment and Schizophrenia: The role of Cannabis Use Cécile Henquet 1 Robin Murray 2 Don Linszen 3 Jim van Os 1,2 1) Department of Psychiatry and Neuropsychology, South Limburg Mental Health Research
More informationCannabis Skunk Sense (CanSS) CANNABIS INFORMATION Websites(written info) Mentor UK FRANK The Site John Moores University
CANNABIS INFORMATION Websites(written info) TYPE OF ORGANISATION (HR is Harm Reduction) FORM of CANNABIS CBD CANNABIDIOL (antipsychotic) METHOD OF USE Cannabis Skunk Sense (CanSS) Prevention charity Aim:
More informationMarijuana and Madness: The Etiology, Evolution, and Clinical Expression of Psychoses
Marijuana and Madness: The Etiology, Evolution, and Clinical Expression of Psychoses Kaitlyn Enright Kaitlyn is pursuing her M.Sc. degree at McGill University. Her research project focuses on delineating
More informationDoes cannabis use increase the risk of developing psychosis or schizophrenia? CANNABIS EVIDENCE BRIEF
Does cannabis use increase the risk of developing psychosis or schizophrenia? CANNABIS EVIDENCE BRIEF BRIEFS AVAILABLE IN THIS SERIES: Is cannabis safe to use? Facts for youth aged 13 17 years. Is cannabis
More informationNeurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP
Neurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP Disclosures This speaker has no conflicts of interest to disclose Objectives Define drug abuse and addiction Identify the
More informationKeep off the grass? Cannabis, cognition and addiction
Keep off the grass? Cannabis, cognition and addiction H. Valerie Curran* 1, Tom P. Freeman 1, Claire Mokrysz 1, David A. Lewis 2, Celia J. A. Morgan 1,3 & Loren H. Parsons 4 1 Clinical Psychopharmacology
More informationThe Effects of Cannabis on the Developing Brain: From Prenatal Development Through Early Adulthood
The Effects of Cannabis on the Developing Brain: From Prenatal Development Through Early Adulthood Kyle E. Ferguson, Ph.D. Providence St. Peter Family Medicine Residency Program October 20, 2014 Disclosure
More informationEffects of acute ketamine infusion on visual working memory encoding: a study using ERPs
Effects of acute ketamine infusion on visual working memory encoding: a study using ERPs Corinna Haenschel Psychology, City University London, UK Partly Funded by: the Welsh Institute of Cognitive Neuroscience
More informationMedical Cannabis MATT WEBSTER DO, MS
Medical Cannabis MATT WEBSTER DO, MS Cannabis Sativa One of the oldest used drugs and medicinal remedies Most commonly abused illicit drug in the US There has been increasing access for medicinal MJ use
More informationProportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study
Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study Marta Di Forti, Arianna Marconi, Elena Carra, Sara Fraietta, Antonella
More information9/13/2017. Marijuana and the Brain Matthew Wong, MD Assistant Professor, Department of Neurology, Epilepsy Section. Disclosures.
Marijuana and the Brain Matthew Wong, MD Assistant Professor, Department of Neurology, Epilepsy Section Disclosures Site principal investigator of studies of cannabidiol(epidiolex) in the treatment of
More informationInvestigational Pharmacy Cannabidiol treatment in Epilepsy
Jon Beck BS Pharm D Coordinator Investigational Pharmacy Disclosure I have no relevant financial relationships with a Commercial Provider Nebraska Medicine Omaha, NE Investigational Pharmacy Cannabidiol
More informationMarijuana: How Safe is This Plant?"
Marijuana: How Safe is This Plant?" Lukasz M. Konopka AM, PhD, ECNS Spectrum Center for Integrative Neuroscience, McHenry IL June 14, 2017 Spectrumin.com 23rd Annual Summer Institute on Addictions No
More informationCANNABIS AND CANADA S CHILDREN AND YOUTH CPS Podcast
CANNABIS AND CANADA S CHILDREN AND YOUTH CPS Podcast Developed by KEON MA and Dr. CHRISTINA GRANT for PedsCases.com July 6, 2018 INTRODUCTION: Keon: On June 21, 2018, Bill C-45, also known as the Cannabis
More informationEffects of Marijuana On Brain, Body & Behavior. Nora D. Volkow, M.D. Director
Effects of Marijuana On Brain, Body & Behavior Nora D. Volkow, M.D. Director Marijuana is the Most Commonly Used Illicit Drug In the U.S. Over 111 million Americans have tried it at least once An estimated
More informationDr. Meldon Kahan. Women s College Hospital. with PIA LAW
with PIA LAW and Toronto ABI Network Dr. Meldon Kahan Women s College Hospital Dr. Meldon Kahan is an Associate Professor in the Department of Family Medicine at University of Toronto, and Medical Director
More informationIs cannabis responsible for early onset psychotic illnesses?
EDITORIAL For reprint orders, please contact: reprints@futuremedicine.com Is cannabis responsible for early onset psychotic illnesses? Alain Dervaux 1,2 Marie-Odile Krebs2,3 Xavier Laqueille1 Several prospective
More informationDebunking Marijuana MythsON THE TEENAGE BRAIND
Debunking Marijuana MythsON THE TEENAGE BRAIND Harold C. Urschel III, MD, MMA March 7, 2018 All contents copyright 2018 Enterhealth LLC ADDICTION IS A SPECTRUM DISORDER Alcohol and drug use falls along
More informationMarijuana. Module 4 ALLIED TRADES ASSISTANCE PROGRAM PREVENTATIVE EDUCATION: SUBSTANCE USE DISORDER
Marijuana Module 4 ALLIED TRADES ASSISTANCE PROGRAM PREVENTATIVE EDUCATION: SUBSTANCE USE DISORDER Marijuana Pot Grass Weed Reefer Herb Mary Jane MJ Whatever you call it, marijuana is the nations most
More informationJNJ : selective and slowly reversible FAAH inhibitor. Central and Peripheral PK/PD
JNJ-42165279: selective and slowly reversible FAAH inhibitor Central and Peripheral PK/PD The Endocannabinoid System Research initiated by efforts to elucidate the active substance of Cannabis (THC in
More informationThe Neurobiology of Psychiatric Disorders
The Neurobiology of Psychiatric Disorders Vikaas S. Sohal, MD PhD Department of Psychiatry Center for Integrative Neuroscience Sloan Swartz Center for Theoretical Neurobiology Overview 1. Classification
More informationTransition to psychosis in Cannabis abusers
Western University From the SelectedWorks of Amresh Srivastava May, 2013 Transition to psychosis in Cannabis abusers Amresh Srivastava, University of Western Ontario Available at: https://works.bepress.com/amreshsrivastava/141/
More informationNeuropsychiatric Effects of Cannabis
Neuropsychiatric Effects of Cannabis Igor Grant, MD University of California, San Diego Center for Medicinal Cannabis Research Cannabis and Neuropsychiatry: Overview! Purpose: to review the effects of
More informationSchizophrenia: Biology and Etiology. Schizophrenia: The basics. What is schizophrenia? Good Question!!
Schizophrenia: Biology and Etiology Carlsson and Lindqvist 1963 Daniel R. Weinberger, M.D. Genes, Cognition and Psychosis Program National Institute of Mental Health, NIH Bethesda, Maryland 20892 USA weinberd@mail.nih.gov
More informationCannabinoids 101. Matthew Hill, Ph.D. Hotchkiss Brain Institute University of Calgary
Cannabinoids 101 Matthew Hill, Ph.D. Hotchkiss Brain Institute University of Calgary Disclosures Have received honoraria for Scientific Consultation: Pfizer International GW Pharmaceuticals Receive operating
More informationMedical Marijuana A Primer for Pharmacists
Medical Marijuana A Primer for Pharmacists Emory S. Martin, PharmD FASHP Texas Society of Health System Pharmacists Learning Objectives Recognize key components of the endocannabinoid system Identify possible
More information4/15/2019. US States with Marijuana Laws in Have ACOG and SMFM taken notice? THE EFFECTS OF MARIJUANA USE ON PREGNANCY AND LACTATION
THE EFFECTS OF MARIJUANA USE ON PREGNANCY AND LACTATION Susan R Davidson, MD Maternal Fetal Medicine Department of Ob/Gyn St. Mary s Hospital Madison, WI SSM Health I HAVE NO FINANCIAL DISCLOSURES TO REPORT
More informationTHE GRASS IS ALWAYS GREENER: TBI AND THE CLINICAL UTILITY OF MEDICAL MARIJUANA
THE GRASS IS ALWAYS GREENER: TBI AND THE CLINICAL UTILITY OF MEDICAL MARIJUANA JOE TRETTEL, MD, PHD THE CHASE FAMILY MOVEMENT DISORDERS CENTER, HHC GAYLE KLEIN, MD OUTLINE AND OBJECTIVES 1. The Problem:
More informationCannabis and the Developing Brain: What s the buzz about?
Cannabis and the Developing Brain: What s the buzz about? DR PHILIP TIBBO P R O F E S S O R D R P A U L J A N S S E N C H A I R I N P S Y C H O T I C D I S O R D E R S D A L H O U S I E U N I V E R S I
More informationBrain Imaging Studies on the Cognitive, Pharmacological and Neurobiological Effects of Cannabis in Humans: Evidence from Studies of Adult Users
Send Orders for Reprints to reprints@benthamscience.ae REVIEW ARTICLE Current Pharmaceutical Design, 2016, 22, 1-14 1 Brain Imaging Studies on the Cognitive, Pharmacological and Neurobiological Effects
More informationMarijuana. How is Marijuana Abused? How Does Marijuana Affect the Brain?
Marijuana Marijuana is the most commonly abused illicit drug in the United States. It is a dry, shredded green and brown mix of flowers, stems, seeds, and leaves derived from the hemp plant Cannabis sativa.
More informationFederal Law: Marijuana
Federal Law: Marijuana Marijuana is a Schedule I drug under Federal Controlled Substances Act Makes possession, usage, purchase, sale, and/or cultivation of marijuana illegal at the federal level May not
More informationLecture: Medical Marijuana Long term effects and interac ons with common medicines Neuropharamacology of the brain with cannabis
Lecture: Medical Marijuana Long term effects and interac ons with common medicines Neuropharamacology of the brain with cannabis William Morrone, DO Robert Piccinini, DO Endocannabinoids in Disease and
More informationKeep off the grass? Cannabis, cognition and addiction
Keep off the grass? Cannabis, cognition and addiction H. Valerie Curran 1, Tom P. Freeman 1, Claire Mokrysz 1, David A. Lewis 2, Celia J. A. Morgan 1,3 and Loren H. Parsons 4 Abstract In an increasing
More informationThe Neurobiology of Mood Disorders
The Neurobiology of Mood Disorders J. John Mann, MD Professor of Psychiatry and Radiology Columbia University Chief, Department of Neuroscience, New York State Psychiatric Institute Mood Disorders are
More informationWeek 2: Disorders of Childhood
Week 2: Disorders of Childhood What are neurodevelopmental disorders? A group of conditions with onset in the developmental period Disorders of the brain The disorders manifest early in development, often
More informationThe Neurobiology of Addiction
The Neurobiology of Addiction Jodi Gilman, Ph.D. Center for Addiction Medicine Massachusetts General Hospital Associate Professor, Department of Psychiatry Harvard Medical School What is Addiction? commonly
More informationMedical Marijuana in Canada, 2014: Panacea or Blowing Smoke. Dr. Paul Daeninck Mr. Brent Zettl
Medical Marijuana in Canada, 2014: Panacea or Blowing Smoke Dr. Paul Daeninck Mr. Brent Zettl Presenter Disclosure Presenter: Brent Zettl Relationships with commercial interests: President and CEO of Prairie
More informationAbstracts and affiliations
Dopamine Discovery Day August 30, 2012 Rikshospitalet Store auditorium, Oslo, Norway Organized by Linda H. Bergersen & Vidar Gundersen Institute of Basic Medical Sciences & Centre for Molecular Biology
More informationSchizophrenic twin. Normal twin
Brain anatomy and activity are often abnormal in schizophrenics - many studies have found the ventricles in schizophrenic patients enlarged (see below). - at the structural level, several brain areas have
More informationThe Nervous System Mark Stanford, Ph.D.
The Nervous System Functional Neuroanatomy and How Neurons Communicate Mark Stanford, Ph.D. Santa Clara Valley Health & Hospital System Addiction Medicine and Therapy Services The Nervous System In response
More informationPRACTICAL APPLICATIONS OF CANNABIS IN TREATING POST- TRAUMATIC STRESS DISORDER (PTSD) Bryan Krumm, CNP
PRACTICAL APPLICATIONS OF CANNABIS IN TREATING POST- TRAUMATIC STRESS DISORDER (PTSD) Bryan Krumm, CNP What is Post-Traumatic Stress Disorder? The person experiences, witnesses, or is confronted with an
More informationCANNABINOIDS: NOVEL MOLECULES WITH SIGNIFICANT CLINICAL UTILITY
CANNABINOIDS: NOVEL MOLECULES WITH SIGNIFICANT CLINICAL UTILITY NOEL ROBERT WILLIAMS MD FACOG DIRECTOR OPTIMAL HEALTH ASSOCIATES OKLAHOMA CITY, OKLAHOMA How Did We Get Here? In November 2012 Tikun Olam,
More informationYOUR BRAIN IS NOT COMPLETELY DEVELOPED UNTIL YOU ARE 25 YEARS OLD. FIRST CHANCE- MODULAR TWO -MARIJUANA
YOUR BRAIN IS NOT COMPLETELY DEVELOPED UNTIL YOU ARE 25 YEARS OLD. FIRST CHANCE- MODULAR TWO -MARIJUANA cgregoreva2014 1 Cannabis and adolescence: A dangerous cocktail cgregoreva2014 2 Disclaimer Disclaimer:
More informationWhat has research over the past two decades revealed about the adverse health effects of recreational cannabis use?
1 What has research over the past two decades revealed about the adverse health effects of recreational cannabis use? Wayne Hall 1,2,3 1. The University of Queensland Centre for Youth Substance Abuse Research,
More informationBertha K Madras, PhD Professor of Psychobiology Department of Psychiatry Harvard Medical School McLean Hospital
Bertha K Madras, PhD Professor of Psychobiology Department of Psychiatry Harvard Medical School McLean Hospital bmadras@partners.org Users The Brain Adolescent Marijuana Safety Marijuana and Opioids Protecting
More informationThe Role of Smoking in Cocaine. Addiction
The Role of Smoking in Cocaine Addiction Luca Colnaghi Eric Kandel Laboratory Columbia University in the City of New York Department of Neuroscience Index 1- The Brain, memory, metaplasticity 2- Cocaine
More informationWHAT SHOULD WE KNOW ABOUT MARIJUANA
WHAT SHOULD WE KNOW ABOUT MARIJUANA Marijuana is the most commonly used illicit drug in the U.S. The use of marijuana can produce adverse physical, mental, emotional, and behavioral effects. What is marijuana?
More informationCBD and Your Health.
CBD and Your Health. Cannabidiol (CBD) is a molecule found in plant species such as agricultural (or industrial) hemp, and Echinacea. CBD is one of at least 489 distinct compounds within hemp: it is clear
More informationDrugs, addiction, and the brain
Drugs, addiction, and the brain Topics to cover: What is addiction? How is addiction studied in the lab? The neuroscience of addiction. Caffeine Cocaine Marijuana (THC) What are the properties of addiction?
More informationFunctional neuroimaging in schizophrenia: diagnosis and drug discovery
Review Functional neuroimaging in schizophrenia: diagnosis and drug discovery Philip McGuire 1, Oliver D Howes 1, James Stone 2 and Paolo Fusar-Poli 1 1 Sections of Neuroimaging, Division of Psychological
More informationWashtenaw Community College Comprehensive Report. PSY 296 Neuropsychology of Addiction Effective Term: Winter 2019
Washtenaw Community College Comprehensive Report PSY 296 Neuropsychology of Addiction Effective Term: Winter 2019 Course Cover Division: Humanities, Social and Behavioral Sciences Department: Behavioral
More informationNNF Årsmøtekonferanse
U N I V E R S I T Y O F B E R G E N Department of Biological and Medical Psychology Cannabis use in non-affective psychoses: Relationship to age at onset, cognitive functioning and social cognition NNF
More informationBiomarkers Workshop In Clinical Trials Imaging for Schizophrenia Trials
Biomarkers Workshop In Clinical Trials Imaging for Schizophrenia Trials Research focused on the following areas Brain pathology in schizophrenia and its modification Effect of drug treatment on brain structure
More informationMarijuana and Health
Marijuana and Health MNCAMH June Webinar June 9, 2017 Ken Winters, Ph.D. Adjunct Faculty, Dept. of Psychology University of Minnesota & Senior Scientist, Oregon Research Institute winte001@umn.edu Web-Based
More informationNeurobiology of Addiction
Neurobiology of Addiction Domenic A. Ciraulo, MD Director of Alcohol Pharmacotherapy Research Center for Addiction Medicine Department of Psychiatry Massachusetts General Hospital Disclosure Neither I
More informationDisease Modification in Schizophrenia: Overview of the Issues. ISCTM February 18 th 2014 Ravi Anand, MD Switzerland
Disease Modification in Schizophrenia: Overview of the Issues ISCTM February 18 th 2014 Ravi Anand, MD Switzerland Need for a New Treatment Paradigm in Schizophrenia Sixty years after approval for the
More informationMOLECULAR BIOLOGY OF DRUG ADDICTION. Sylvane Desrivières, SGDP Centre
1 MOLECULAR BIOLOGY OF DRUG ADDICTION Sylvane Desrivières, SGDP Centre Reward 2 Humans, as well as other organisms engage in behaviours that are rewarding The pleasurable feelings provide positive reinforcement
More informationShift 1, 8 July 2018, 09:30-13:00
Shift 1, 8 July 2018, 09:30-13:00 CNS patterning A001-A014 Stem cells: basic biology and postnatal neurogenesis - part I Development of neural systems: Molecular and genetic characterisationa Epigenetic
More informationCannabis in the Community
Department of Pediatrics Cannabis in the Community The Unintended Consequences of Increased Marijuana Availability on the Pediatric Population Karen Buchi, MD Professor of Pediatrics Chair, University
More information